Background: The utility of sentinel lymph node biopsy (SLNB) in older patients remains controversial. Advancements in HER2-directed therapy have revolutionized disease response rates and prognosis, supporting efforts to reevaluate the utility of...
Background: Metastatic breast cancer (MBC) is incurable, despite recent therapeutic advances resulting in extended trajectories of disease, especially in estrogen receptor positive (ER+) and human epidermal growth factor-2 negative (HER2-) MBC....